14.12
Edgewise Therapeutics Inc Borsa (EWTX) Ultime notizie
Edgewise Therapeutics, Inc. (EWTX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
What analysts say about Edgewise Therapeutics Inc. stockRapidly growing investment returns - PrintWeekIndia
Jennison Associates LLC Takes Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Readystate Asset Management LP Raises Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Why Edgewise Therapeutics Inc. stock attracts strong analyst attentionSmart Money Signals - Newser
What drives Edgewise Therapeutics Inc. stock priceRapid wealth accumulation - Autocar Professional
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Edgewise Therapeutics, Inc. (EWTX) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Edgewise Therapeutics Inc. Stock Analysis and ForecastMarket-leading growth rates - Autocar Professional
Becker Muscular Dystrophy Pipeline 2025: Key Companies, MOA, - openPR.com
BlackRock, Inc. Reduces Stake in Edgewise Therapeutics Inc. - GuruFocus
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Purchased by Arizona State Retirement System - Defense World
Is Edgewise Therapeutics Inc. a good long term investmentConsistently superior profits - jammulinksnews.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Edgewise Therapeutics, Inc. (EWTX) And Encourages Investors to Reach Out - ACCESS Newswire
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc.EWTX - MarketScreener
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc.EWTX - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Edgewise Therapeutics, Inc. (EWTX) And Encourages Stockholders to Reach Out - ACCESS Newswire
EWTX Investors Have Opportunity to Join Edgewise Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - The Globe and Mail
When is the best time to buy Edgewise Therapeutics Inc. stockSmart Growth Low Risk Picks - Newser
why edgewise therapeutics inc. stock attracts strong analyst attentionFree Professional Portfolio Management - Newser
What makes Edgewise Therapeutics Inc. stock price move sharplyQuick Profit Idea Stream - Newser
How Edgewise Therapeutics Inc. stock performs during market volatilityShort Squeeze Radar - Newser
Edgewise Therapeutics (NASDAQ:EWTX) Stock Price Up 7.9%Time to Buy? - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Edgewise Therapeutics Reports Positive Results for Muscular Dystrophy Treatment - MSN
(EWTX) Trading Report - news.stocktradersdaily.com
User - FinancialContent
Edgewise Therapeutics (NASDAQ:EWTX) Now Covered by HC Wainwright - Defense World
HC Wainwright Initiates Edgewise Therapeutics With Buy Rating, $42 Price Target - MarketScreener
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):